RxDoctor Payments Data

Stephanie Williams, APRN

Family · Zephyrhills, FLNPI 1578006839

Payments from drug & device makers

$1,504in general payments, 2019–2025

Across 78 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$330
  • Lilly USA, LLC$321
  • Pfizer$138
  • AstraZeneca$124
  • Amgen$97
  • AbbVie$91
  • plus $402 from 12 others

What the payments were for

  • Food & beverage$1,504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,504 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$31,394
Medicare patients
171
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$67,789
XareltoRivaroxaban35$37,396
EliquisApixaban34$32,518
TrulicityDulaglutide29$30,247
FarxigaDapagliflozin Propanediol21$27,376
JardianceEmpagliflozin26$24,674
MounjaroTirzepatide23$21,789
RybelsusSemaglutide16$14,799
JanuviaSitagliptin Phosphate15$12,624
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$5,304
SynthroidLevothyroxine Sodium52$4,142
Atorvastatin Calcium385$3,943
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,010
Omeprazole138$2,146
Duloxetine Hcl37$2,066

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$330$82,58876 claims
Lilly USA, LLCTrulicity, Mounjaro$321$52,03652 claims
Johnson & JohnsonXarelto$19$37,39635 claims
PfizerEliquis$138$32,51834 claims
AstraZenecaFarxiga$124$27,37621 claims
Boehringer IngelheimJardiance$47$24,67426 claims
AbbVieSynthroid$91$4,14252 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.

Other family in Zephyrhills

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →